Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities

Journal of Child Neurology

Volumn 18, Issue 2, 2003, Pages 109-112

  Gucuyener, Kivilcim ^a   Erdemoglu, A Kemal ^b   Senol, Selahattin ^a   Serdaroglu, Ayşe ^a   Soysal, Sebnem ^a   Kockar, Ilden ^a  

^a GAZI UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; METHYLPHENIDATE;

ADOLESCENT; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EEG ABNORMALITY; EPILEPSY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SLEEP DISORDER; STATISTICAL ANALYSIS; STOMACH PAIN; SYMPTOMATOLOGY; TIC;

EID: 0345700831     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180020601     Document Type: Article

References (27)

1. Cantwell DP: Attention deficit disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996;35:978-987.
2. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-1086.
3. Miller KJ, Castellanos FX: Attention deficit/hyperactivity disorders. Pediatr Rev 1998;19:373-384.
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, APA Press, 1994.
5. Barkley RA: Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, Guilford, 1990, 573-612.
6. Kinsbourne M, Graf WD: Disorders of mental development, in Menkes JH, Sarnat HB (eds): Child Neurology, 6th ed. Philadelphia, Lippincott Williams and Wilkins, 2000, 1155-1211.
7. Shaywits BA, Flietcher JM, Shaywits SE: Attention deficit hyperactivity disorder, in Swaiman KF, Ashwall S (eds): Pediatric Neurology Principles and Practice, 3rd ed. St Louis, Mosby, 1999, 585-597.
8. Stein MA, Blondis TA, Schnitzler ER, et al: Methylphenidate dosing: Twice daily versus three times daily. Pediatrics 1996;98:748-756.
9. Feldman H, Crumrine P, Handen BL, et al: Methylphenidate in children with seizures and attention deficit disorder. Am J Dis Child 1989;143:1081-1086.
10. Mc Bride M, West Torres C: Methylphenidate in therapeutic doses does not lower threshold. Ann Neurol 1986;20:428.
11. Semrud-Clikeman M, Wical B: Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999,40:211-215.
12. Gross-Tsur V, Manor O, van der Meere J, et al: Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? J Pediatr 1997;130:40-44.
13. Hemmer SA, Pasternak JF, Zecker SG, Trommer BL: Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 2001;24:99-102.
14. Finck S, Metz-Lutz M-N, Becache E, et al: Attention-deficit hyperactivity disorder in epileptic children: A new indication for methylphenidate? Ann Neurol 1995;38:520.
15. Goyette CH, Conners CK, Ulrich RF: Normative data on revised Conners'Parent and Teacher Rating Scales. J Abnorm Child Psychol 1978;6:221-236.
16. American Academy of Pediatrics, Committee on Drugs: Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics 1995;96:538-540.
17. Ross EM, Peckham CS, West PB: Epilepsy in childhood: Findings from the National Child Development Study. BMJ 1980;1:207-210.
18. Sillanpaa M: Epilepsy in children: Prevalence, disability and handicap. Epilepsia 1992;33:444-449.
19. Bennet-Levy J, Stores G: The nature of cognitive dysfunction in school children with epilepsy. Acta Neurol Scand Suppl 1984;99:79-82.
20. Lindsay J, Ounsted C, Richards P: Long-term outcome in children with temporal lobe epilepsy. Dev Med Child Neurol 1984;26:25-32.
21. Powell AL, Yudd A, Zee P, Mandelbaum DE: Attention deficit hyperactivity disorder associated with orbitofrontal epilepsy in a father and a son. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:151-154
22. Williams J, Sharp G, Lange B, et al: The effects of seizure type, level of seizure control, and antiepileptic drugs on memory and attention skills in children with epilepsy. Dev Neuropsychol 1996;12:241-253.
23. Safer D, Zito JM, Fine EM: Increased methylphenidate usage for attention deficit disorder in the 1990's. Pediatrics 1996;98:1084-1088.
24. Efron D, Jarman F, Barker M: Side effects of methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder: A double-blind cross-over trial. Pediatrics 1997;100:662-666.
25. Klein RG, Wender P: The role of methylphenidate in psychiatry. Arch Gen Psychiatry. 1995;52:429-433.
26. Physicians' Desk Reference. Oradell, NJ, Medical Economics, 1988.
27. Wroblewski BA, Leary JM, Phelan AM, et al: Methylphenidate and seizure frequency in brain-injured patients with seizure disorders. J Clin Psychiatry 1992;53:86-89.